Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Butcher

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Annals of Neurology|February 20, 2022
Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT StudiesAmrou Sarraj, Mark Parsons, Andrew Bivard, et al.
Science (New York, N.Y.)|January 27, 2022
The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cellsRafael D Melani, Vincent R Gerbasi, Lissa C Anderson, et al.
Stroke|March 4, 2026
Perihematomal Edema and Functional Outcome After Intracerebral Hemorrhage: A Meta-Analysis of Individual Participant DataNeshika Samarasekera, Sharon Tuck, Xia Wang, et al.
Lancet (London, England)|May 27, 2019
Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient dataBruce C V Campbell, Henry Ma, Peter A Ringleb, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
The Lancet. Neurology|November 11, 2018
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level dataBruce C V Campbell, Charles B L M Majoie, Gregory W Albers, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Annals of Neurology|February 20, 2022
Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT StudiesAmrou Sarraj, Mark Parsons, Andrew Bivard, et al.
Science (New York, N.Y.)|January 27, 2022
The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cellsRafael D Melani, Vincent R Gerbasi, Lissa C Anderson, et al.
Stroke|March 4, 2026
Perihematomal Edema and Functional Outcome After Intracerebral Hemorrhage: A Meta-Analysis of Individual Participant DataNeshika Samarasekera, Sharon Tuck, Xia Wang, et al.
Lancet (London, England)|May 27, 2019
Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient dataBruce C V Campbell, Henry Ma, Peter A Ringleb, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
The Lancet. Neurology|November 11, 2018
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level dataBruce C V Campbell, Charles B L M Majoie, Gregory W Albers, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Pageof 14